SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-001773
Filing Date
2019-02-12
Accepted
2019-02-12 16:51:44
Documents
6
Period of Report
2019-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 34058
2 ex1-1.htm EX-1.1 253284
3 ex5-1.htm EX-5.1 10453
4 ex99-1.htm EX-99.1 13185
5 ex99-2.htm EX-99.2 10363
6 ex99-3.htm EX-99.3 12245
  Complete submission text file 0001493152-19-001773.txt   334754
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 19591604
SIC: 2835 In Vitro & In Vivo Diagnostic Substances